APOE and Alzheimer disease: Again the post-10D5 treatment number of hemosiderin deposits in APP/ε3 mice was the lowest among all APOE genotypes, indicating a relative vasculoprotective effect of the ε3 allele, which has not been previously described in AD patients or APP Tg mice expressing human APOE alleles.